True Health: Physician Referrals Through Laboratory MSOs

In the True Health civil settlement, the laboratory’s former chief executive agreed to pay $4.25 million to resolve allegations that he arranged payments for physicians’ laboratory referrals. In its September 8, 2025 announcement, the Justice Department alleged that the payments carried investment, consulting and specimen-handling labels, and that the executive kept the management services organization arrangement going after receiving warnings about the marketers. For someone who handled the distributions, approved the fees or watched the orders arrive, those are recognizable business decisions.

True Health Diagnostics was a laboratory in Frisco, Texas. The allegations resolved by its former chief executive’s agreement concerned false claims to Medicare, Medicaid and TRICARE from January 2015 through May 2018. The government alleged that marketers, including True Health employees, offered doctors payments disguised as investment distributions from management services organizations to induce testing referrals.

How the Alleged MSO Payments Reached Physicians

The alleged payment route ran from hospitals through recruiters and management services organizations to physicians who ordered laboratory tests. In the government’s complaint, small Texas hospitals paid recruiters to arrange referrals, and the recruiters passed part of those payments to the referring providers. Those providers ordered True Health or Boston Heart Diagnostics tests through the hospitals or directly from the laboratories.

The government’s June 28, 2022 physician-settlement announcement describes the connection between the hospital’s payment and the physician’s return. Little River Healthcare allegedly paid volume-based commissions to independent recruiters, who used management services organizations to pay doctors. The government said the supposed investment returns were based on, and offered in exchange for, the doctors’ referrals. The distribution had an investment label. The alleged calculation followed the orders.

A management services organization supplies contracted administrative functions, while the professional entity supplies clinical services. Ownership and operating control can sit in different hands, so the management agreement and the payment calculation describe different parts of the business. We look at what the physician invested, what the management company actually supplied and what generated the return. The person preparing the distributions may know that answer more clearly than anyone reading the claim for the test.

What Are Kickbacks in Health Care?

Kickbacks in health care are payments or other benefits exchanged to induce referrals or orders. The Justice Department alleged that True Health’s former chief executive arranged healthcare kickbacks through management services organization distributions, consulting fees, processing and handling fees, and waived copayments and deductibles.

A processing or handling fee describes a service connected to a specimen, while a copayment adjustment changes what the patient is asked to pay. We examine those records alongside the referral business: who performed the promised work, who received the benefit and which laboratory orders followed. The government’s allegation ties those benefits to the executive’s effort to induce testing referrals.

The same combination appears in A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, published by the Journal of Forensic and Investigative Accounting in 2020. Its discussion of the Berkeley Heartlab allegations separates processing-and-handling payments for referrals, unnecessary genetic testing and copayment waivers intended to induce more orders. That analysis makes an operational distinction worth keeping: the fee paid to obtain the order, the medical reason for the test and the patient’s bill are different parts of the transaction.

The payment description can change from one business to another. In North Carolina laboratory-referral settlements announced on April 29, 2024, the Justice Department alleged payments disguised as rent, phlebotomy payments or purchases of used laboratory equipment. A practice employee who knows the space, specimen work or equipment can explain what the invoice was supposed to buy and what actually changed hands.

The Warning Reached the Chief Executive

The government alleged that True Health’s former chief executive facilitated continued participation after receiving a warning that the marketers “are a powder keg waiting to explode on us.” That language appears in the settlement announcement’s account of the warnings. We see a warning treated as background noise while the referral arrangement allegedly kept running.

The government’s complaint also places the wider referral-payment scheme after an earlier industry warning. It alleges that the scheme began around August 2014, two months after the Health and Human Services Office of Inspector General’s laboratory-payment alert. For an insider, the meaningful connection is what management was told and what it authorized afterward. A response to a warning can explain why the next payment matters.

We compare warnings with the later agreements, distributions and orders to understand that sequence. Someone who saw a response drafted, a payment approved or the referral arrangement continue can explain decisions that the laboratory claim alone would never describe. The business correspondence belongs beside the money trail.

Why the Hospital Billing Route Mattered

The hospital route mattered because the government alleged it increased reimbursement for the laboratory work. The complaint also connects the referral scheme to unnecessary testing, calling out both allegations in the same passage, with Little River identified as LRH:

Those allegations connect the referral payment to both what was ordered and how it reached the government bill. The laboratory’s testing records, the physician’s order and the hospital’s claim describe different decisions. We see an alleged arrangement that rewarded the people directing the tests while exposing patients to unnecessary panels and leaving taxpayers with the bill. A hospital biller or laboratory employee may know how the specimen’s actual path differed from the service described on the claim.

The Executive, Physicians and Marketers Settled Separately

The Justice Department’s announcement also described separate agreements by a Plano physician to pay $124,627 and a Denton physician to pay $234,215 over alleged referral payments. The Plano physician allegedly received payments from Ascend MSO of TX LLC and Herculis MG LLC. The Denton physician allegedly received payments from Ascend MSO and Eridanus MG LLC.

Seven marketers and their associated businesses agreed to pay $1,459,620 over allegations that they paid doctors through purported management services organizations. The group included former True Health and Boston Heart sales employees and owners of LGRB Management Services LLC and Next Level Healthcare Consultants LLC.

The executive’s agreement was one part of a wider investigation that, by that announcement, had produced more than $59 million in civil False Claims Act settlements, including recoveries from 50 physicians. The payment obligations reached the people allegedly arranging the referrals as well as the people receiving money for them.

What a Laboratory Insider Can Connect

An insider can connect the payment’s stated purpose to the work, referrals and government claims behind it. The evidence may sit in records that different departments keep: investment terms and distribution calculations, consulting and handling invoices, or adjustments to patient balances. We work with the person who understands how those records were created and what decisions they reflect.

The clinical and billing side completes the account. Orders, specimen-routing records, test results and hospital claims can connect the payment arrangement to particular services billed to Medicare, Medicaid or TRICARE. An employee who knows only the laboratory’s side can still explain where the testing went, while someone in a physician practice may understand why the orders kept coming. We bring those perspectives together around the alleged exchange.

How Much of a Settlement Does a Whistleblower Get?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. The case against True Health’s former chief executive began with a whistleblower’s qui tam suit, and the United States joined the case against him. The announcement allocated a share of his settlement to the whistleblower.

You Saw What Kept the Orders Coming

If you handled laboratory distributions, approved consulting fees or saw a referral arrangement continue after a warning, speak to one of our whistleblower experts about the payments that kept the orders coming. We build the case with you around the payments and decisions you know, and bring in laboratory kickback whistleblower lawyers who understand the connection between physician orders and government claims. You have a partner in us from the first account of the arrangement through the pursuit of a recovery.